Crossmark

Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series

Crossref DOI link: https://doi.org/10.1016/j.rpsm.2021.10.003

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ertuğrul, Aygün https://orcid.org/0000-0001-9885-9849
Anıl Yağcıoğlu, A. Elif https://orcid.org/0000-0002-3269-150X
Ağaoğlu, Esen https://orcid.org/0000-0001-5247-3609
Karakaşlı, Ahmet Alp https://orcid.org/0000-0002-1472-1437
Ak, Sertaç https://orcid.org/0000-0002-7372-5809
Yazıcı, M. Kâzım https://orcid.org/0000-0002-0963-2747
Leon, Jose de https://orcid.org/0000-0002-7756-2314
License Information

Text and Data Mining valid from 2022-10-01
More Information

This article is maintained by: Elsevier

Article Title: Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series

Journal Title: Revista de Psiquiatría y Salud Mental

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rpsm.2021.10.003

Content Type: article

Copyright: © 2021 SEP y SEPB. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below